SARS-CoV-2
RNA STAR Complete
LumiraDx SARS-CoV-2 RNA STAR Complete is a rapid, non-isothermal nucleic acid amplification qSTAR method intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal swabs collected from individuals suspected of COVID-19 by their healthcare provider (HCP).
- Reliable and robust performance when compared to traditional RT-PCR tests
- Direct amplification within 20 minutes drives lab's efficiency and productivity
- Based on in silico analysis we confirm detection of all known circulating variants including Omicron, Omicron B.2 and Delta
Test Workflows
Performance
Join the Fast Lab Network
For more information about LumiraDx SARS-CoV-2 RNA STAR Complete:
Not all products are available in all countries and regions. Please check with your local LumiraDx sales representative or distributor for availability in specific markets.
BetterHealthExperiencesOutcomes
Supporting healthier lives, for individuals, communities and wider society.
Enabling responsive, personal relationships between patients and care teams.
Controlling and reducing costs to help ease pressure on healthcare budgets.